Nonrheumatic aortic valve disorders
ICD-10 I35 is a used to indicate a diagnosis of nonrheumatic aortic valve disorders.
Nonrheumatic aortic valve disorders encompass a range of conditions affecting the aortic valve that are not caused by rheumatic fever. These disorders can include aortic stenosis, aortic regurgitation, and aortic valve insufficiency. Clinically, patients may present with symptoms such as dyspnea, angina, syncope, or heart failure, depending on the severity of the valve dysfunction. The aortic valve is located between the left ventricle and the aorta, and its proper function is crucial for maintaining adequate blood flow from the heart to the systemic circulation. Disease progression can lead to significant hemodynamic changes, resulting in left ventricular hypertrophy and eventual heart failure if left untreated. Diagnostic considerations include echocardiography, which is the primary imaging modality used to assess valve structure and function, as well as cardiac catheterization in certain cases to evaluate the severity of the condition. Regular monitoring and timely intervention are essential to manage these disorders effectively.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I35 covers nonrheumatic aortic valve disorders, including aortic stenosis, aortic regurgitation, and aortic valve insufficiency. These conditions may arise from degenerative changes, congenital defects, or other non-inflammatory causes.
I35 should be used when the aortic valve disorder is specifically nonrheumatic in nature. If the condition is due to rheumatic fever, the appropriate code would be I34. Accurate differentiation is crucial for proper coding and treatment planning.
Documentation should include clinical findings from physical examinations, echocardiographic results, and any relevant imaging studies. Detailed notes on symptoms, functional status, and treatment plans are also essential to support the use of I35.
